Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

Joan Gavaldà, Óscar Len, José María Aguado et al. · Clinical Infectious Diseases · 2005 · 314 citations

Life Sciences, Immunology, Infectious Diseases +17

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

Manuel Cuenca‐Estrella, Alicia Gómez‐López, Emilia Mellado et al. · Antimicrobial Agents and Chemotherapy · 2006 · 298 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

Nina Singh, Shahid Husain · The Journal of Heart and Lung Transplantation · 2003 · 293 citations

Medicine, Infectious Diseases, Microbiology +14

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

Richard H. Drew, Elizabeth Dodds Ashley, Daniel K. Benjamin et al. · Transplantation · 2004 · 198 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

H. Reichenspurner, P. Gamberg, M. Nitschke et al. · Transplantation Proceedings · 1997 · 151 citations

Medicine, Infectious Diseases, Microbiology +17